Singapore: AI takes the spotlight in the healthcare industry as Singapore focuses efforts on AI deployment

In brief

The Singapore government has once again recognised the importance of AI in the healthcare industry, outlining a three-pronged approach on how to harness the potential of AI in the industry. 

In the long-run, the increasing use of AI would serve to deliver better diagnosis and treatment; early detection, prevention and prediction of diseases; faster drug development; and better understand the risks around intervention and how to stratify it. In the shorter term, the use of AI may help to enhance clinical decision support; increase productivity of healthcare teams; and support individuals.


Contents

In more detail

During the second edition of the AI Health Summit 2023, Dr. Janil Puthucheary, Senior Minister of State of the Ministry of Health, delivered a speech concerning the use of AI in the healthcare industry.

Dr. Puthucheary recognised that by embracing and adopting AI in the healthcare sector, it can facilitate better diagnosis and treatment, help with early detection and prevention of diseases, and enhance drug development processes.

To increase the productivity of the healthcare sector and benefit patients, Singapore is adopting a three-pronged approach towards the use of AI:

  1. The development of enablers and common platforms to facilitate collaboration and allow easy deployment of AI models across different institutions; 
  2.  Working with partners to better equip healthcare professionals with skills to employ AI in their work; and 
  3. Embracing new AI technologies, such as generative AI, in a safe and secure manner to benefit patients.

One development relating to developing enablers is the implementation of common platforms for AI deployment around a variety of sites. One such platform is the AI Medical Imaging Platform for Singapore Public Healthcare (AimSG), launched by Synpaxe, Singapore's national healthtech agency, and Singhealth, Singapore's largest group of healthcare institutions.

To equip healthcare professionals with relevant skills, SingHealth and AI Singapore, Singapore's national programme to boost AI capability, has signed a memorandum of understanding where healthcare professionals will receive AI training and qualification catered to the industry. There will be joint research and innovation projects to facilitate the sharing of knowledge. The education videos are scheduled to begin in June 2024, and include both e-learning programmes and physical workshops.

Once again, the Singapore government has stressed the risks that may accompany the use of AI. Synpaxe is working with industry partners to build generative AI applications with built-in data security safeguards to ensure the integrity of patient data even as AI is being applied to streamline healthcare processes.

Key takeaways

The Singapore government's positioning indicates opportunities in the industry for the development and deployment of AI. Companies looking to venture into the AI and/or healthtech space should be mindful of the applicable regulations and guidelines to the deployment of AI in health products and/or services.

 

* * * * *

LOGO_Wong&Leow_Singapore

© 2023 Baker & McKenzie.Wong & Leow. All rights reserved. Baker & McKenzie.Wong & Leow is incorporated with limited liability and is a member firm of Baker & McKenzie International, a global law firm with member law firms around the world. In accordance with the common terminology used in professional service organizations, reference to a "principal" means a person who is a partner, or equivalent, in such a law firm. Similarly, reference to an "office" means an office of any such law firm. This may qualify as "Attorney Advertising" requiring notice in some jurisdictions. Prior results do not guarantee a similar outcome.

Contact Information

Copyright © 2024 Baker & McKenzie. All rights reserved. Ownership: This documentation and content (Content) is a proprietary resource owned exclusively by Baker McKenzie (meaning Baker & McKenzie International and its member firms). The Content is protected under international copyright conventions. Use of this Content does not of itself create a contractual relationship, nor any attorney/client relationship, between Baker McKenzie and any person. Non-reliance and exclusion: All Content is for informational purposes only and may not reflect the most current legal and regulatory developments. All summaries of the laws, regulations and practice are subject to change. The Content is not offered as legal or professional advice for any specific matter. It is not intended to be a substitute for reference to (and compliance with) the detailed provisions of applicable laws, rules, regulations or forms. Legal advice should always be sought before taking any action or refraining from taking any action based on any Content. Baker McKenzie and the editors and the contributing authors do not guarantee the accuracy of the Content and expressly disclaim any and all liability to any person in respect of the consequences of anything done or permitted to be done or omitted to be done wholly or partly in reliance upon the whole or any part of the Content. The Content may contain links to external websites and external websites may link to the Content. Baker McKenzie is not responsible for the content or operation of any such external sites and disclaims all liability, howsoever occurring, in respect of the content or operation of any such external websites. Attorney Advertising: This Content may qualify as “Attorney Advertising” requiring notice in some jurisdictions. To the extent that this Content may qualify as Attorney Advertising, PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME. Reproduction: Reproduction of reasonable portions of the Content is permitted provided that (i) such reproductions are made available free of charge and for non-commercial purposes, (ii) such reproductions are properly attributed to Baker McKenzie, (iii) the portion of the Content being reproduced is not altered or made available in a manner that modifies the Content or presents the Content being reproduced in a false light and (iv) notice is made to the disclaimers included on the Content. The permission to re-copy does not allow for incorporation of any substantial portion of the Content in any work or publication, whether in hard copy, electronic or any other form or for commercial purposes.